These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 22469709)

  • 1. Pancreatic resection for metastases from renal cancer: long term outcome after surgery and immunotherapy approach - single center experience.
    Gardini A; Morgagni P; Milandri C; Riccobon A; Ridolfi R; La Barba G; Saragoni L; Amadori D; Garcea D
    Hepatogastroenterology; 2012 May; 59(115):687-90. PubMed ID: 22469709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The place of enucleation and enucleo-resection in the treatment of pancreatic metastasis of renal cell carcinoma.
    Yazbek T; Gayet B
    JOP; 2012 Jul; 13(4):433-8. PubMed ID: 22797401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pancreatic metastasis of renal cell carcinoma: presentation, treatment and survival.
    Faure JP; Tuech JJ; Richer JP; Pessaux P; Arnaud JP; Carretier M
    J Urol; 2001 Jan; 165(1):20-2. PubMed ID: 11125354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival data justifies resection for pancreatic metastases.
    Strobel O; Hackert T; Hartwig W; Bergmann F; Hinz U; Wente MN; Fritz S; Schneider L; Büchler MW; Werner J
    Ann Surg Oncol; 2009 Dec; 16(12):3340-9. PubMed ID: 19777190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pulmonary metastases of the clear cell (conventional) renal cell carcinoma--options and results of surgical treatment].
    Vodicka J; Spidlen V; Simánek V; Safránek J; Fichtl J; Mukensnabl P; Fínek J; Rousarová M
    Klin Onkol; 2011; 24(4):293-7. PubMed ID: 21905621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcome of immunotherapy for patients with refractory pancreatic cancer.
    Nakamura M; Wada J; Suzuki H; Tanaka M; Katano M; Morisaki T
    Anticancer Res; 2009 Mar; 29(3):831-6. PubMed ID: 19414316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancreatic resection for metastatic tumors to the pancreas.
    Sperti C; Pasquali C; Liessi G; Pinciroli L; Decet G; Pedrazzoli S
    J Surg Oncol; 2003 Jul; 83(3):161-6; discussion 166. PubMed ID: 12827684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological features and surgical outcome of isolated metastasis of renal cell carcinoma.
    Akatsu T; Shimazu M; Aiura K; Ito Y; Shinoda M; Kawachi S; Tanabe M; Ueda M; Kitajima M; Kitagawa Y
    Hepatogastroenterology; 2007 Sep; 54(78):1836-40. PubMed ID: 18019729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metastatic renal cell carcinoma with concurrent inferior vena caval invasion: long-term survival after combination therapy with radical nephrectomy, vena caval thrombectomy and postoperative immunotherapy.
    Naitoh J; Kaplan A; Dorey F; Figlin R; Belldegrun A
    J Urol; 1999 Jul; 162(1):46-50. PubMed ID: 10379737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metastatic pancreatic tumors: what is the optimal treatment?
    Sperti C; Merigliano S; Moletta L
    Minerva Chir; 2015 Apr; 70(2):131-9. PubMed ID: 25645113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of relapse and response to retreatment in patients with metastatic melanoma or renal cell carcinoma who responded to interleukin-2-based immunotherapy.
    Lee DS; White DE; Hurst R; Rosenberg SA; Yang JC
    Cancer J Sci Am; 1998; 4(2):86-93. PubMed ID: 9532410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors.
    Norton JA; Kivlen M; Li M; Schneider D; Chuter T; Jensen RT
    Arch Surg; 2003 Aug; 138(8):859-66. PubMed ID: 12912744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term results of surgical management of pulmonary metastases from renal cell carcinoma.
    Marulli G; Sartori F; Bassi PF; dal Moro F; Gino Favaretto A; Rea F
    Thorac Cardiovasc Surg; 2006 Dec; 54(8):544-7. PubMed ID: 17151970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of pancreatic resection for cancer metastatic to the pancreas.
    Sweeney AD; Wu MF; Hilsenbeck SG; Brunicardi FC; Fisher WE
    J Surg Res; 2009 Oct; 156(2):189-98. PubMed ID: 19375718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgery for metastasis to the pancreas: is it safe and effective?
    Niess H; Conrad C; Kleespies A; Haas F; Bao Q; Jauch KW; Graeb C; Bruns CJ
    J Surg Oncol; 2013 Jun; 107(8):859-64. PubMed ID: 23637007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcome of combined immunotherapy with interferon-alpha and low-dose interleukine-2 for Japanese patients with metastatic renal cell carcinoma.
    Miyake H; Kurahashi T; Takenaka A; Inoue TA; Fujisawa M
    Urol Oncol; 2009; 27(6):598-603. PubMed ID: 18818106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancreatic resection for metastatic renal cell carcinoma: a single center experience and review of the literature.
    Schauer M; Vogelsang H; Siewert JR
    Anticancer Res; 2008; 28(1B):361-5. PubMed ID: 18383870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No role of adjuvant systemic therapy after complete metastasectomy in metastatic renal cell carcinoma?
    Kwak C; Park YH; Jeong CW; Lee SE; Ku JH
    Urol Oncol; 2007; 25(4):310-6. PubMed ID: 17628297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcome after percutaneous treatment of transitional cell carcinoma of the renal pelvis.
    Patel A; Soonawalla P; Shepherd SF; Dearnaley DP; Kellett MJ; Woodhouse CR
    J Urol; 1996 Mar; 155(3):868-74. PubMed ID: 8583595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Local recurrence of renal cell carcinoma after nephrectomy].
    Pereverzev AS; Shchukin DV; Iliukhin IuA
    Urologiia; 2003; (6):14-8. PubMed ID: 14708237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.